Stanford Medicine researchers have identified a primary driver of biological aging: the failure of tissue-resident macrophages to clear senescent, or “zombie,” neutrophils from the body. According to a study published July 16 in Science, blocking a specific pro-inflammatory receptor, EP2, on these immune cells rejuvenated organ function and reduced age-related frailty in mice. This discovery … Read more
Research from the University of Virginia (UVA) Comprehensive Cancer Center indicates that a buildup of bile acids, triggered by an unhealthy gut microbiome, can drive hormone receptor-positive (HR+) breast cancer to metastasize to other organs, particularly the lungs. According to Melanie Rutkowski, PhD, this mechanism suggests that FDA-approved bile acid sequestrants or microbiome replenishment could … Read more
Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more
Obesity May Fuel Leukemia Growth, Study Reveals Obesity may act as a catalyst for leukemia progression, according to a study led by Indiana University School of Medicine researchers. Published in the Journal of Clinical Investigation, the findings suggest that chronic inflammation linked to obesity creates an environment where leukemia cells thrive. The work, conducted by … Read more
Researchers at VCU Massey Comprehensive Cancer Center have developed an experimental molecule called an autophagy-targeting chimera (AUTAC) that dismantles the MCL1 survival protein to kill multiple myeloma cells. According to a study published in Cell Death & Disease, this targeted protein degrader works with existing proteasome inhibitors to reduce cancer cell viability by 50% within … Read more
A systematic review published in Scientific Reports found no statistically significant increase in major congenital malformations, stillbirths, or preterm births following maternal exposure to GLP-1 receptor agonists. While the data offers “cautious reassurance” for inadvertent exposure, researchers state the evidence certainty remains low, meaning these medications are not yet considered safe for routine use during … Read more
Medicare prescriptions for the anti-obesity medication Wegovy surged 598% in the six months following a federal policy shift that allowed coverage for heart disease prevention. Despite this increase, new research from the USC Schaeffer Center for Health Policy & Economics reveals that less than 1% of the estimated 3.6 million eligible beneficiaries have accessed the … Read more
Researchers at the University at Buffalo have developed an artificial intelligence method to detect cortical lesions in multiple sclerosis (MS) patients using existing MRI scans. By analyzing relationships between multiple contrast images, this AI-driven approach reveals invisible gray matter damage, providing a new metric for tracking disease progression and cognitive impairment, according to a study … Read more
Researchers at the University of Massachusetts Amherst have developed an artificial intelligence model called MycoPermeNet to accelerate the discovery of tuberculosis drugs. By combining this AI with a high-throughput screening technique known as PAC-MAN, the team can predict which chemical compounds can penetrate the bacterium’s unique mycomembrane, potentially speeding up the search for effective treatments … Read more
Breakthrough in Antibiotic Resistance: Targeting Bacterial Enzymes How the Study Uncovered a New Approach Antibiotic resistance, a global health crisis linked to 4.7 million deaths in 2019, has seen a critical breakthrough. Researchers at Scripps Research discovered that disabling a bacterial enzyme called secreted antigen A (SagA) makes vancomycin-resistant Enterococcus faecium (VREfm) vulnerable to vancomycin. … Read more